Currently, there are 233.85M common shares owned by the public and among those 225.81M shares have been available to trade.
Insiders at the company have transacted a total of 0 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 0 of these insider trades were purchases, accounting for 0 shares. Insider sales of the common stock occurred on 0 occasions, with total insider shares sold totaling 0 shares.
The company’s stock has a 5-day price change of 2.74% and 12.25% over the past three months. CRWD shares are trading 14.03% year to date (YTD), with the 12-month market performance up to 20.36% higher. It has a 12-month low price of $200.81 and touched a high of $455.59 over the same period. CRWD has an average intraday trading volume of 3.35 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -6.26%, 1.04%, and 17.03% respectively.
Institutional ownership of Crowdstrike Holdings Inc (NASDAQ: CRWD) shares accounts for 69.86% of the company’s 233.85M shares outstanding.
It has a market capitalization of $96.10B and a beta (3y monthly) value of 1.26. The stock’s trailing 12-month PE ratio is 770.46, while the earnings-per-share (ttm) stands at $0.51. The company has a PEG of 37.86 and a Quick Ratio of 1.76 with the debt-to-equity ratio at 0.26. Price movements for the stock have been influenced by the stock’s volatility, which stands at 5.91% over the week and 4.25% over the month.
Earnings per share for the fiscal year are expected to increase by 11.95%, and 26.79% over the next financial year.
Looking at the support for the CRWD, a number of firms have released research notes about the stock. Robert W. Baird stated their Neutral rating for the stock in a research note on February 03, 2025, with the firm’s price target at $390-$430. Citigroup coverage for the Crowdstrike Holdings Inc (CRWD) stock in a research note released on January 17, 2025 offered a Buy rating with a price target of $420. Needham was of a view on November 27, 2024 that the stock is Buy, while HSBC Securities gave the stock Hold rating on November 27, 2024, issuing a price target of $347. Exane BNP Paribas on their part issued Neutral rating on October 08, 2024.
